Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2025 16:01 ET | Source: Robbins LLP

Kyverna Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Class Action Against KYTX

Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTX) Provided Investors with Misleading Information in Connection with its IPO
December 13, 2024 16:18 ET | Source: Robbins LLP

Kyverna Therapeutics, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the KYTX Class Action Lawsuit

Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTK) Provided Investors with Misleading Information in Connection with its IPO